| 11661 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11662 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11663 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11664 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11665 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11666 |
SERUM HYALURONIC ACID (HA) AS A NEW NON INVASIVE MARKER FOR ASSESSING HEPATIC FIBROSIS & CIRRHOSIS |
Department of Medical Physiology |
2007 |
| 11667 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Dermatology |
2007 |
| 11668 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Clinical Pathology |
2007 |
| 11669 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Clinical Pathology |
2007 |
| 11670 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Clinical Pathology |
2007 |